| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
163,710,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
3,100,847 |
Avg
Vol: |
1,431,820 |
| 52
Week Range: |
$81.44 - $81.44 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Luce Michael D |
*See Remarks |
– – • |
2008-09-30 |
4 |
S |
$26.18 |
$4,917,019 |
D/D |
(187,572) |
1,109,722 |
|
- |
|
| Luce Michael D |
*See Remarks |
– – • |
2008-09-29 |
4 |
S |
$27.30 |
$3,551,730 |
D/D |
(130,100) |
1,175,432 |
|
- |
|
| Seely Lynn |
Chief Medical Officer |
• – – |
2008-09-25 |
4 |
AS |
$29.57 |
$266,117 |
D/D |
(9,000) |
0 |
|
- |
|
| Seely Lynn |
Chief Medical Officer |
• – – |
2008-09-25 |
4 |
OE |
$3.60 |
$32,400 |
D/D |
9,000 |
9,000 |
|
- |
|
| Machado Clarence Patrick |
Sr. Vice President and CFO |
• – – |
2008-09-25 |
4 |
AS |
$29.64 |
$296,394 |
I/I |
(10,000) |
426,123 |
|
- |
|
| Hung David |
President and CEO |
• • – |
2008-09-25 |
4 |
AS |
$29.62 |
$742,248 |
D/D |
(25,000) |
1,474,641 |
|
- |
|
| Bailey Gregory |
Director |
– • – |
2008-09-17 |
4 |
AS |
$29.70 |
$653,404 |
I/I |
(22,000) |
250,508 |
|
- |
|
| Blickenstaff Kim D |
Director |
– • – |
2008-09-11 |
4 |
S |
$33.05 |
$661,046 |
D/D |
(20,000) |
0 |
|
- |
|
| Blickenstaff Kim D |
Director |
– • – |
2008-09-11 |
4 |
OE |
$3.75 |
$75,000 |
D/D |
20,000 |
20,000 |
|
- |
|
| Protter Andrew A |
VP, Preclinical Development |
• – – |
2008-09-03 |
4 |
AS |
$31.85 |
$509,579 |
D/D |
(16,000) |
0 |
|
- |
|
| Protter Andrew A |
VP, Preclinical Development |
• – – |
2008-09-03 |
4 |
OE |
$5.35 |
$85,600 |
D/D |
16,000 |
16,000 |
|
- |
|
| Luce Michael D |
*See Remarks |
– – • |
2008-09-03 |
4 |
B |
$29.94 |
$14,970,000 |
D/D |
500,000 |
1,219,666 |
2.45 |
- |
|
| Protter Andrew A |
VP, Preclinical Development |
• – – |
2008-09-02 |
4 |
AS |
$25.00 |
$171,250 |
D/D |
(6,850) |
0 |
|
- |
|
| Protter Andrew A |
VP, Preclinical Development |
• – – |
2008-09-02 |
4 |
OE |
$5.35 |
$36,648 |
D/D |
6,850 |
6,850 |
|
- |
|
| Protter Andrew A |
VP, Preclinical Development |
• – – |
2008-08-29 |
4 |
AS |
$25.00 |
$28,750 |
D/D |
(1,150) |
0 |
|
- |
|
| Protter Andrew A |
VP, Preclinical Development |
• – – |
2008-08-29 |
4 |
OE |
$5.35 |
$6,153 |
D/D |
1,150 |
1,150 |
|
- |
|
| Luce Michael D |
*See Remarks |
– – • |
2008-08-01 |
4 |
B |
$20.01 |
$1,680,840 |
D/D |
84,000 |
2,120,667 |
2.45 |
- |
|
| Luce Michael D |
10% Owner |
– – • |
2008-07-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,075,000 |
|
- |
|
| Bailey Gregory |
Director |
– • – |
2008-07-21 |
4 |
AS |
$19.00 |
$355,243 |
I/I |
(18,697) |
272,508 |
|
- |
|
| Bailey Gregory |
Director |
– • – |
2008-07-18 |
4 |
AS |
$19.00 |
$62,757 |
I/I |
(3,303) |
291,205 |
|
- |
|
| Machado Clarence Patrick |
Sr. Vice President and CFO |
• – – |
2008-06-09 |
4 |
AS |
$14.90 |
$149,036 |
I/I |
(10,000) |
436,123 |
|
- |
|
| Seely Lynn |
Chief Medical Officer |
• – – |
2008-06-09 |
4 |
AS |
$14.94 |
$134,426 |
D/D |
(9,000) |
0 |
|
- |
|
| Seely Lynn |
Chief Medical Officer |
• – – |
2008-06-09 |
4 |
OE |
$3.60 |
$32,400 |
D/D |
9,000 |
9,000 |
|
- |
|
| Hung David |
President and CEO |
• • – |
2008-06-09 |
4 |
AS |
$14.89 |
$372,248 |
D/D |
(25,000) |
1,499,641 |
|
- |
|
| Adams Daniel |
Director |
– • – |
2008-03-12 |
4 |
AS |
$13.65 |
$139,126 |
D/D |
(10,190) |
0 |
|
- |
|
506 Records found
|
|
Page 17 of 21 |
|
|
